We are pleased to announce that The Advisory Board Company has recognized HI-IQ as a valuable tool for monitoring Quality Assurance in the interventional radiology department. In their recent Imaging Performance Partnership report entitled, "Measuring Quality in Interventional Radiology" The Advisory Board Company assessed the current state of Quality Assurance in interventional radiology. The report describes the required characteristics of a QA program in IR with specific attention focused on granular complications tracking and radiation dosage tracking. HI-IQ was singled out as a comprehensive Quality Assurance database, meeting the IR department's need to monitor performance.
The Advisory Board Company is a leading health care services firm providing best practices research and implementation services in business strategy and clinical operations. Serving the country's preeminent hospitals, health care systems, pharmaceutical companies and insurers, The Advisory Board provides executive education, strategic planning and decision facilitation, and process redesign and improvement services through its membership practice and H*Works implementation service.
HI-IQ has been designed by interventional radiologists, for interventional radiologists, and there’s no question that it could not have achieved this distinction from The Advisory Board Company without input from users like you. Many thanks for your contribution to HI-IQ’s success, and we look forward to continuing to support your robust IR program into the future.
For more information about The Advisory Board Company visit: www.advisory.com.
For more information about HI-IQ’s Quality Assurance module visit: http://www.hi-iq.com/qa.aspx.